Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

What Stakeholders Think About CER: Now in a Booklet and at a Conference Near You

June 25, 2013

When you say “CER,” what are people thinking? The findings from NPC’s annual survey of health care stakeholders and their opinions of comparative effectiveness research and the environment for decision-making are now available in a new booklet (print and online as a PDF, along with an archived webinar). According to the survey results, stakeholders have growing expectations for the use of CER as a tool for improving health care decision-making. Their views also have changed from previous years in terms of which organizations were expected to play a significant role in specific aspects of CER, such as research priorities, methods and standards.

The survey’s findings further detail where stakeholders expect CER to go within the next 3-5 years, and what organizations they expect to lead each aspect of funding and conducting the research.

NPC research staff are presenting the survey results at two meetings this week. Health Research Services Director Kimberly Westrich will deliver remarks tomorrow at the Drug Information Association Annual Meeting in Boston, and Research Associate Adam Lustig presented a poster at the AcademyHealth Annual Research Meeting in Baltimore, Maryland.

Blog Post

CER Tweets of the Week: The Challenges of Gray-Zone Medicine, PCORI in the Congress Blog (January 12-16)

This week, comparative effectiveness research (CER) stakeholders tweeted multiple articles regarding CER and various challenges they face. They...
Blog Post

CER Tweets of the Week: AcademyHealth Compares International CER, Resource Library on CER (January 5-9)

This week, comparative effectiveness research (CER) stakeholders tweeted about @AcademyHealth’s new paper comparing international efforts to boost...
Blog Post

CER Tweets of the Week: Clinical Uncertainty in Surgery and EBM & Patient-Centered Medicine and EBM (December 29 – January 2)

This week, articles about evidence-based medicine (EBM) attracted the attention of comparative effectiveness research (CER) stakeholders on Twitter....
Blog Post

CER Tweets of the Week (December 22-26): PCORI Offers Up to $150.7 Million to Support PCORnet Phase II; Views on Evidence-Based Medicine

In addition to sharing the latest news about the Patient-Centered Outcomes Research Institute’s latest grants and PCORnet, comparative effectiveness...
Press Release

Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council

Washington, D.C. (December 9, 2014)—The National Pharmaceutical Council (NPC) today welcomed two leading biopharmaceutical companies—Biogen Idec and...
Press Release

Eisai’s David Martin Elected as National Pharmaceutical Council’s Chairman of the Board

[[{"fid":"32030","view_mode":"teaser","fields":{"format":"teaser","field_file_image_alt_text[und][0][value]":"dave-martin","...
Press Release

Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council and Milken Institute School of Public Health at The George Washington University

WASHINGTON, DC (September 17, 2014)–The National Pharmaceutical Council (NPC), in conjunction with Milken Institute School of Public Health (Milken...
Press Release

Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research

Washington, DC (July 31, 2014)—The National Pharmaceutical Council (NPC) today announced that Michael Ciarametaro has joined the health policy...
Commentary and Testimony Page

NPC Comments on PCORI Proposal for Peer Review of Primary Research and Public Release of Research Findings

November 7, 2014Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite 900Washington, DC 20036Dear Dr....
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study suggesting that changes are needed...
YouTube Videos

CER and the Environment for Health Care Decision-Making

The National Pharmaceutical Council’s (NPC) fourth annual survey of health care stakeholders is continuing to shed light on the current environment...
YouTube Videos

Webinar: CER Collaborative: Tools You Can Use

Collaborative members hosted a webinar explaining how to use the tools they developed to create greater uniformity and transparency when evaluating...
YouTube Videos

Patient Input on What Makes Comparative Effectiveness Research Useful

Myrl Weinberg, chief executive officer of the National Health Council, says that many patients are still concerned about how comparative...
Blog Post

CER Tweets of the Week: The Challenges of Gray-Zone Medicine, PCORI in the Congress Blog (January 12-16)

This week, comparative effectiveness research (CER) stakeholders tweeted multiple articles regarding CER and various challenges they face. They...
Blog Post

CER Tweets of the Week: AcademyHealth Compares International CER, Resource Library on CER (January 5-9)

This week, comparative effectiveness research (CER) stakeholders tweeted about @AcademyHealth’s new paper comparing international efforts to boost...
Blog Post

CER Tweets of the Week: Clinical Uncertainty in Surgery and EBM & Patient-Centered Medicine and EBM (December 29 – January 2)

This week, articles about evidence-based medicine (EBM) attracted the attention of comparative effectiveness research (CER) stakeholders on Twitter....
Blog Post

CER Tweets of the Week (December 22-26): PCORI Offers Up to $150.7 Million to Support PCORnet Phase II; Views on Evidence-Based Medicine

In addition to sharing the latest news about the Patient-Centered Outcomes Research Institute’s latest grants and PCORnet, comparative effectiveness...

Research

  •  
  • 1 of 13
  • >

Commentary & Testimony